Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuss

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1Joshua E Reuss, Nofisat Ismaila, Amith Ahluwalia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1Joshua E Reuss, Sara Kuruvilla, Nofisat Ismaila, et al.
Immunotherapy|July 3, 2026
Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysisNicolas Peruzzo, Gabriel Lenz, Rafael Alvim Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3Dwight H Owen, Nofisat Ismaila, Amith Ahluwalia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTsSabrina Rossi, Daniela Gasparotto, Matilde Cacciatore, et al.
Clinical Lung Cancer|January 3, 2025
Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic CarcinomaJennifer A Marks, Jaeil Ahn, Joshua E Reuss, et al.
Acta Neuropathologica Communications|March 4, 2018
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometryRémi Longuespée, Annika K Wefers, Elena De Vita, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2026
Clinical utility of sarcoma methylation classifiers in soft tissue sarcoma diagnosisJustus Osterloh, David E Reuss, Andreas von Deimling, et al.
Clinical Lung Cancer|June 10, 2025
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisNicolas Peruzzo, Gabriel Lenz, Ted Akhiwu, et al.
Free Neuropathology|March 27, 2024
Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtypeDavid E Reuss, Daniel Schrimpf, Asan Cherkezov, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1Joshua E Reuss, Nofisat Ismaila, Amith Ahluwalia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1Joshua E Reuss, Sara Kuruvilla, Nofisat Ismaila, et al.
Immunotherapy|July 3, 2026
Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysisNicolas Peruzzo, Gabriel Lenz, Rafael Alvim Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3Dwight H Owen, Nofisat Ismaila, Amith Ahluwalia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTsSabrina Rossi, Daniela Gasparotto, Matilde Cacciatore, et al.
Clinical Lung Cancer|January 3, 2025
Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic CarcinomaJennifer A Marks, Jaeil Ahn, Joshua E Reuss, et al.
Acta Neuropathologica Communications|March 4, 2018
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometryRémi Longuespée, Annika K Wefers, Elena De Vita, et al.
Journal of Cancer Research and Clinical Oncology|May 16, 2026
Clinical utility of sarcoma methylation classifiers in soft tissue sarcoma diagnosisJustus Osterloh, David E Reuss, Andreas von Deimling, et al.
Clinical Lung Cancer|June 10, 2025
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisNicolas Peruzzo, Gabriel Lenz, Ted Akhiwu, et al.
Free Neuropathology|March 27, 2024
Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtypeDavid E Reuss, Daniel Schrimpf, Asan Cherkezov, et al.
Pageof 14